Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
November 2017—Sciex Diagnostics showcased its Sciex Topaz System at the 4th Annual European Congress and Exhibition of the Association for Mass Spectrometry: Applications to the Clinical Lab in Salzburg, Austria, in September.
November 2017—GenomeDx Biosciences and Pathnostics announced a strategic agreement for GenomeDx to distribute Pathnostics’ Guidance UGx for urinary tract infections and Guidance PRx for prostatitis. These molecular diagnostic tests detect the genomic sequence of pathogens, providing a faster and more comprehensive solution for physicians and their patients.
November 2017—Immunalysis Corp. announced that its Fentanyl Urine Sefria Drug Screening Kit has been granted FDA 510(k) clearance for the qualitative detection of fentanyl in urine. It is the first analyte on the Sefria diagnostic platform.
November 2017—Roche announced the expanded use of the Ventana PD-L1 (SP142) Assay in non-small cell lung cancer and metastatic urothelial carcinoma in CE markets in which the Roche cancer immunotherapy medicine Tecentriq is approved.
November 2017—IntegraGen announced the CE-IVD marking and commercial launch of its miRpredX 31-3p test kit in the European Union.
November 2017—Blood Systems Research Institute announced a collaboration with Hologic to more precisely and efficiently measure the human immunodeficiency virus latent reservoir in clinical samples using Hologic’s Panther system.
November 2017—Royal Philips announced that two pathology laboratories in Austria have made the transition to a fully digital workflow. The Pathology Institute in Hall and the Pathology Institute at Tirol Kliniken Innsbruck have fully digitized their diagnostic process with Philips IntelliSite Pathology Solution, a whole slide imaging system for primary diagnosis.
November 2017—Vector Laboratories introduced the VectaFluor Duet kit, offering ready-to-use immunofluorescence double labeling. This kit is ideal for use on a range of frozen and formalin-fixed, paraffin-embedded tissue samples, combining primary and secondary antibodies to streamline workflow.
November 2017—Tetracore announced that its T-Cor 8 portable real-time PCR thermocycler has achieved CE-IVD status. The T-Cor 8, and its proprietary software, is a point-of-care diagnostic system that enables real-time molecular testing in hospitals, clinics, physician offices, and field applications.
November 2017—The Clinical and Laboratory Standards Institute has published “Developing and Managing a Medical Laboratory (Test) Utilization Program (GP49),” which provides guidance on the process for developing and effectively maintaining a test utilization or laboratory stewardship committee.
